Thu Sep 20 02:14:45 +08 2018  
HIV PEP (post-exposure prophylaxis): Stop HIV infection within 3 days after unprotected sex.
HIV test: 20 minute rapid test to accurately detect HIV infection 28 days after unprotected sex.
STD testing: Full & comprehensive sexually transmitted disease testing.

Cryotherapy | SINGAPORE GUM™


Cryotherapy | SINGAPORE GUM™ @singaporegum_com: , Singapore. Private & confidential service.

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.


Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception (females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing.
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception (females only)
2 weeks HIV DNA PCR test
1 month 20 minute rapid HIV test - SD Bioline HIV Ag/Ab Combo:
- Fingerprick blood sampling.
3 months 20 minute rapid HIV test - OraQuick®:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.


Latest News

Mp18-16 propensity score matched comparison of partial to whole gland cryotherapy for intermediate-risk prostate cancer: an analysis of the cold registry data
Mon, 28 Mar 2016 19:24:01 +0100 | The Journal of Urology
Patients with intermediate-risk prostate cancer constitute a unique group of patients in whom cure may be both necessary and possible. While there has been increasing interest in partial gland therapies to reduce the morbidity of treatment, randomized comparisons to whole gland therapies have been lacking. We aim to compare the oncological and functional outcomes of partial versus whole gland cryotherapy for intermediate-risk prostate cancer. (Source: The Journal of Urology)

Mp18-13 primary focal cryotherapy in the treatment of predominantly anterior and high volume intermediate and high-risk localized prostate cancer in the uk
Mon, 28 Mar 2016 19:24:01 +0100 | The Journal of Urology
Focal cryotherapy may offer good oncological outcomes with minimal side-effects. We recently commenced a focal cryotherapy program, primarily for anterior or transition zone lesions, to complement our focal HIFU programme. We assessed safety, adverse-events, functional outcomes and disease control. (Source: The Journal of Urology)

Mp18-05 is salvage focal cryotherapy curative treatment for patients with localized recurrent prostate cancer?
Mon, 28 Mar 2016 19:24:01 +0100 | The Journal of Urology
The salvage therapy options for patients with recurrent unilateral prostate cancer after primary radiation, or cryotherapy are limited. Salvage focal cryotherapy is becoming a more popular treatment option as it has shown success in its disease free survival rates. Salvage focal cryotherapy enables patients to delay or negate the use of hormone therapy which has many unfavorable adverse effects. The aim of this study is to report on the curative success of salvage focal cryotherapy in recurrent unilateral prostate cancer patients. (Source: The Journal of Urology)

Coats' Disease: Very Long-Term Outcome After Early Stage Conventional Treatment.
Sat, 26 Mar 2016 17:54:02 +0100 | Open Ophthalmology Journal
CONCLUSION: About three decades after conventional treatment of Coats' disease stage 2a, treated eyes maintained good VA, and stage 2b eyes did not progress to advanced stages.

The Effect of Intermittent Arm and Shoulder Cooling on Baseball Pitching Velocity
Sat, 26 Mar 2016 10:25:17 +0100 | Journal of Strength and Conditioning Research
This study investigated the effects of intermittent cryotherapy on pitching velocity and subjective measures of recovery and exertion in a simulated baseball game. Trained college-aged male baseball pitchers (n = 8) threw 12 pitches (1 pitch every 20 seconds) per inning for 5 total innings during a simulated pitching start. Between each inning, pitchers received shoulder and arm cooling (AC) or, on a separate occasion, no cooling (NC). All sessions took place in a temperate environment (18.3 ± 2.8° C; 49 ± 4% relative humidity). Pitch speeds were averaged for each participant each inning and overall for 5 innings. Perceived exertion (rating of perceived exertion [RPE]) was recorded at the end of each simulated inning. Perceived recovery (perceived recovery scale [PRS]) was recorded afte...

Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador
Sat, 26 Mar 2016 08:13:15 +0100 | Journal of Lower Genital Tract Disease
Conclusions: Women in the CM arm were less likely to complete care than women in the ST arm. Targeted outreach to underscreened women successfully identified women with higher prevalence of HPV and possibly higher disease burden. (Source: Journal of Lower Genital Tract Disease)

Use of thermo‐coagulation as an alternative treatment modality in a ‘screen and treat' programme of cervical screening in rural Malawi
Tue, 22 Mar 2016 23:00:00 +0100 | International Journal of Cancer
This article is protected by copyright. All rights reserved. (Source: International Journal of Cancer)

Acutus Medical closes $75m Series C round for 3D cardiac mapping tech
Tue, 22 Mar 2016 13:23:37 +0100 | Mass Device
Acutus Medical said today that it closed a Series C funding round worth $75 million for the AcQMap 3D cardiac mapping technology it’s developing – including a contribution from an unnamed strategic investor.

Thermally responsive nanocapsules with independent dual drug release profiles for combined cryotherapy of osteoarthritis
Sun, 20 Mar 2016 18:07:29 +0100 | Osteoarthritis and Cartilage
In this study, diclofenac (DCF) and kartogenin (KGN) were choosing as the combined Osteoarthritis (OA) therapy to induce anti-inflammatory activity and cartilage regeneration. Development of the dual-drug delivery systems which can control the release behavior of each drug independently is desired to optimize their effects. Here, we designed dual drug delivery system with thermo-responsiveness for combined therapy of OA which is composed of pluronic F127 (F127)-chitosan oligosaccharide (COS)-KGN conjugated nanoparticles (F127/COS/KGN) encapsulating DCF. (Source: Osteoarthritis and Cartilage)

Treatment trends for clinically localized prostate cancer. National population analysis: GESCAP group
Sat, 19 Mar 2016 00:00:00 +0100 | Actas Urologicas Espanolas
Conclusions This is the first national European study to evaluate the therapeutic management of localized PC based on the risk group to which the patient belonged. Most young patients (≤65 years) with low-intermediate risk localized PC were treated with surgery, which adheres to the recommendations of the 2010 UAE guidelines. Various therapeutic combinations have been employed for patients with high-risk, locally advanced localized tumors, revealing the need for a multidisciplinary approach ( number: ISRCTN19893319). (Source: Actas Urologicas Espanolas)